Facial Injectable Market Going To Hit $21.57 Billion By 2027 | Industry Participants Growing In North America, Europe, Asia Pacific, Latin America, MEA | Grand View Research, Inc.

Facial Injectable Market Going To Hit $21.57 Billion By 2027 | Industry Participants Growing In North America, Europe, Asia Pacific, Latin America, MEA | Grand View Research, Inc.

“Grand View Research, Inc. – Market Research And Consulting.”
Facial Injectable Market Size, Share & Trends Analysis Report By Product (Collagen, Hyaluronic Acid, Botulinum Toxin Type A, Calcium Hydroxylapatite, Polymer Fillers), By Application, By Region, And Segment Forecasts, 2020 – 2027

The global facial injectable market size is anticipated to reach USD 21.57 billion by 2027, according to a new report by Grand View Research, Inc. It is expected to exhibit a 11.8% CAGR during the forecast period, owing to advancements in facial rejuvenation procedures and the increasing importance of medical aesthetics across the globe.

Development in products and procedures, as well as a change in patient demographics, is helping dermatologists and physicians treat multiple facial areas. These advancements help dermatologists or physicians develop customized treatment for patients and facilitate the use of combination products to obtain better outcomes. All these factors are expected to assist in market growth over the forecast period. Augmented products such as Botulinum Toxin Type A (BoNTA) and Hyaluronic Acid (HA) fillers are used in combination to improve outcomes, especially in the lower face procedures. HA fillers are mostly preferred by physicians due to their better acceptance (few instances of hypersensitivity reactions), biodegradable nature, and high viscosity as well as for the longevity they provide to the restored volume.

Minimally invasive surgeries are used for facial rejuvenation, endoscopy, laparoscopy, arthroscopy, and other procedures. These procedures are gaining popularity over time owing to faster recovery, low instances of postsurgery infections, lower pain, reduced scarring, and high accuracy and maximum benefits. For instance, as per the International Society of Aesthetic Plastic Surgery (ISAPS), more than 23.0 million surgical and nonsurgical cosmetic procedures were performed worldwide in 2017 and the number of HA-based surgeries performed was nearly 3,298,266. Such factors are expected to contribute to the growth of this facial injectables market over the forecast period.

Read Informative Sample Copy @ https://www.grandviewresearch.com/industry-analysis/facial-injectables-industry/request/rs1

U.S. facial injectable market size, by product, 2016 - 2027 (USD Billion)


Further key findings from the study suggest:

  • The hyaluronic acid segment held a lucrative market share in 2019 and is expected to witness a significant CAGR over the forecast period owing to increasing preference for combination treatments, such as hyaluronic acid with BoNTA
  • The BoNTA segment is anticipated to witness the fastest CAGR over the forecast period due to increasing application in aesthetics and therapeutics
  • The aesthetics segment is expected to dominate the market during the forecast period owing to increasing expenditure on aesthetic procedures coupled with rising awareness regarding physical appearance among consumers
  • North America is expected to dominate the facial injectables market over the forecast period due to the growing geriatric population, consumer disposable income, and a surge in the number of facial procedures
  • Some of the key market players are ALLERGAN; Ipsen; Merz Pharma; Suneva Medical, Inc.; Medytox, Inc.; Sinclair Pharma; Bloomage BioTechnology Corporation Limited; Anika Therapeutics, Inc.; Prollenium Medical Technologies Inc.; and Galderma S.A.

Request For Special Pricing @ https://www.grandviewresearch.com/special-pricing/189/rfsp1

Global facial injectable market share, by application, 2019 (%)


Key Topics Covered

Chapter 1. Methodology and Scope

                    1.1. Market segmentation & scope

                    1.2. Information procurement

                        1.2.1. Purchased database

                        1.2.2. GVR’s internal database

                        1.2.3. Secondary sources & third-party perspectives

                        1.2.4. Primary research

                    1.3. Information analysis

                        1.3.1. Data analysis models

                    1.4. Market formulation & data visualization

                    1.5. Data validation & publishing

Chapter 2. Executive Summary

                    2.1. Market Outlook

                    2.2. Segment Outlook

                    2.3. Competitive Insights

Chapter 3. Facial Injectables Market Variables, Trends & Scope

                    3.1. Market Lineage outlook

                        3.1.1. Parent market outlook

                        3.1.2. Related/ancillary market outlook

                    3.2. Penetration & Growth Prospect Mapping

                    3.3. Product Pipeline Analysis

                    3.4. Regulatory Framework

                        3.4.1. Reimbursement framework

                        3.4.2. Standards & Compliances

                    3.5. Market Dynamics

                        3.5.1. Market Driver Analysis

                        3.5.2. Market Restraint Analysis

                    3.6. Facial Injectables: Market Analysis Tools

                        3.6.1. Industry Analysis – Porter’s

                            3.6.1.1. Supplier Power:

                            3.6.1.2. Buyer Power

                            3.6.1.3. Substitution Threat

                            3.6.1.4. Threat from new entrant:

                            3.6.1.5. Competitive rivalry:

                        3.6.2. PESTEL Analysis

                            3.6.2.1. Political Landscape

                            3.6.2.2. Environmental Landscape

                            3.6.2.3. Social Landscape

                            3.6.2.4. Technology Landscape

                            3.6.2.5. Legal Landscape

                        3.6.3. Major Deals & Strategic Alliances Analysis

                            3.6.3.1. Joint Ventures

                            3.6.3.2. Mergers & Acquisitions

                            3.6.3.3. Licensing & Partnership

                            3.6.3.4. Technology Collaborations

                            3.6.3.5. Strategic Divestments

Browse Related Reports

Facial Implant Market Analysis By Product (Chin & Mandibular, Cheek, Nasal, Injectables), By Material (Metal, Biologicals, Polymers, Ceramic), By Procedure (Eyelid Surgery, Facelift Surgery, Rhinoplasty) And Segment Forecasts To 2022

https://www.grandviewresearch.com/industry-analysis/facial-implant-market

Facial Fat Transfer Market Size, Share & Trends Analysis Report By Donor Site (Thigh, Flank), By End Use (Hospitals, Clinics & Surgery Centers), By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2019 – 2026

https://www.grandviewresearch.com/industry-analysis/facial-fat-transfer-market

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States
Website: https://www.grandviewresearch.com/industry-analysis/facial-injectables-industry